Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myota
London, England, United Kingdommyota.io ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
Myota’s prebiotic fiber blends have demonstrated efficacy in clinical trials for improving gut health and metabolic biomarkers. Their Metabolic Booster has shown benefits in pre-diabetic individuals by improving glycemic responses such as HbA1c and fasting blood glucose. The products are also used in NHS clinical trials for Type 2 diabetes and pilot studies for IBS.
- Therapeutic areas
- PsychiatryGastroenterologyEndocrinologyCardiovascular
- Modalities
- Prebiotic dietary supplementMicrobial therapy (via modulation of gut microbiome)Live biotherapeutic product therapy (by mechanism, though not a live organism itself)
- Industry
- Food & Nutrition
02
Partnerships
Suannutra – exclusive distribution agreement covering US/EU/UK except Germany/Austria; co-development/customization of blendsNHS – use in UK National Health Service clinical trials/pilot studies
Beyond the preview
Go deeper on Myota.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Myota.